Clinical trial Recruiting at 1 site Interventional Ages 18 to 35

Oxytocin's effect on how people react when escaping a moving threat

Official title: The Modulatory Affect of Oxytocin on Human Defensive Responses During Dynamic Predator-prey Interactions

Run by University of Electronic Science and Technology of China · NCT07162584 · Data updated 2026-11-12

This test will see if a single dose of nasal oxytocin changes how healthy adults behave, feel, and decide while escaping a simulated moving threat during an MRI session.

More Healthy Aging trials

Quick facts

Study typeInterventional
Ages18 Years to 35 Years
SexAll
Enrollment80 (estimated)
SponsorUniversity of Electronic Science and Technology of China
Academic / other
Locations1 site (Chengdu, Sichuan)
StatusRecruiting
StartedSeptember 13, 2025
Main results expectedJanuary 15, 2026
Study endsJanuary 28, 2026
Registry record updatedOctober 6, 2025
Trial IDNCT07162584 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Healthy adults with no current or past psychiatric or neurological disorders, who are not pregnant, not menstruating, not taking oral contraceptives, and who can safely undergo MRI scanning without metal implants or claustrophobia.

Probably not a fit

People with psychiatric or neurological conditions, pregnant people, those using hormonal contraceptives, or anyone with metal implants or claustrophobia who cannot have an MRI would be excluded and would not benefit from participating.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In a double-blind, between-subject design, healthy participants receive either 24 IU intranasal oxytocin or placebo and complete a dynamic predator–prey escape task in an fMRI scanner. The task varies predator attack speed while participants choose when and where to flee toward a refuge, yielding measures like flight initiation distance and distance to refuge. The study also records skin conductance responses, confidence and anxiety ratings during the task, and a battery of baseline questionnaires. Brain activity during the escape decisions is measured with MRI to link behavioral and physiological responses to neural mechanisms.

Why it matters

Potential benefit: If successful, the results could clarify how oxytocin shifts escape decisions and brain responses to threat, which may help guide new approaches for fear or anxiety disorders.

How similar studies have gone: Previous studies have shown oxytocin can alter fear- and anxiety-related behavior and brain activity, but applying it to a dynamic predator–prey escape paradigm in humans with fMRI is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Healthy subjects without past or current psychiatric or neurological disorders

Exclusion Criteria:

* History of head injury; pregnant, menstruating, taking oral contraceptives; medical or psychiatric illness,
* The presence of metal in the body or claustrophobia.

Where it's running

  • University of Electronic Science and Technology of China
    Chengdu, Sichuan, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.